- BETAplast™, a revolutionary moist wound dressing, was launched in Malaysia on 15 August and Thailand on 1 September 2014
– These marked the beginning of rapid market expansion in South East Asia with Vietnam, Singapore, Indonesia and the Philippines in the pipeline
- BETAplast™ is known as Medifoam® in South Korea and is currently the top moist wound dressing product in the country
SINGAPORE, Nov. 13, 2014 /PRNewswire/ — Mundipharma today announced its plans for rapid brand expansion of the revolutionary moist wound dressing product, BETAplastTM, in South East Asia. BETAplastTM was launched in Malaysia (15 August) and Thailand (1 September), and will next be introduced in Vietnam (Q4, 2014) and Singapore (Q1, 2015). Mundipharma is also looking to penetrate the Indonesian and Filipino wound care markets later in 2015.
Known as Medifoam® in South Korea, BETAplastTM is the first domestically developed moist wound dressing produced by Korea-based bio-medical company, Genewel. BETAplastTM foam range has a proprietary SMARTPORE Technology with dense and small micro-pores at the dressing contact layer in comparison to other foam dressings* that provide optimal wound healing with minimal painful shearing of new tissue during dressing change, resulting in reduced wound trauma.
The top product of its kind in South Korea, Medifoam® is marketed as BETAplast™ in South East Asia and released in multiple formats including foam, hydrocolloid and antimicrobial dressings for chronic wounds, burn treatment and post-surgery wound protection. It is built on the heritage of the BETADINE® range of products, a well-established antisepsis brand in wound care management globally for over 50 years.
Mundipharma has also renewed the packaging of BETAplast™ with a new, polished design and a different colour given to each product within the brand for consumers to easily distinguish between types. In addition, Mundipharma has included detailed explanations of each BETAplastTM product’s characteristics on the packaging to help consumers easily identify which to use for their wounds.
The expansion of the BETAplastTM brand in South East Asia is part of a larger agreement signed by Mundipharma and Genewel in March 2014, for the licensing and marketing of Medifoam® moist wound dressing products by Mundipharma in Asia Pacific, the Middle East, Africa and Latin America.
"We are very excited to be bringing South Korea’s leading wound treatment technology to the region," noted Jong-Ho Lee, General Manager of Mundipharma’s Korean and South East Asian offices. "It will take the quality of care of patients in South East Asia to another level."
Lee also added that "starting with BETAplast™‘s release in Malaysia, Mundipharma plans to accelerate its expansion into other South East Asian markets. We recently launched the product in Thailand, and Vietnam and Singapore are next in the pipeline. We have also set our sights on Indonesia and the Philippines."
*Allevyn, Biatain, Askina, Lyofoam, Permafoam, Suprasorb, Cellosorb, Tielle, Schaumaverband, Mepilex, Polymem
 Park YO, Minn KW, Hur JP. Clinical study of application of Medifoam® (hydrophilic polyurethane foam) dressing to donor site.
 Lee KC, Kwak TI, Lee DS, et al. The effect of Medifoam® dressing on the wound of penile surgery.
 Jang SS, Min KW. Wound dressing after CO2 laser resurfacing using a new dressing material: Medifoam®. J Korean Soc Aesthetic Plastic Surg 2002; 8(2): 149-54.
 Data on File. Test Report for Morphology Compare with Medifoam® N & Commercial dressing. Genewel Co. GTRRD-0001-002.
About Mundipharma Asia Pacific
Mundipharma’s global network of companies are privately owned entities covering the world’s pharmaceutical markets. Mundipharma provides patients across 6 continents with a growing portfolio of 19 products in 5 therapeutic areas, which include moderate-to-severe pain, consumer healthcare, oncology, respiratory disease, rheumatoid arthritis, antisepsis and laxatives. Mundipharma is a prime example of a company that consistently delivers high quality products while standing by the values that represent the company. Our mission is to alleviate the suffering of patients with cancer and non-cancer pain and to substantially improve their quality of life.
For more information please visit: http://www.mundipharma.com.sg.
Regional Communications & Corporate Marketing Director
Asia Pacific, Latin America, Middle East and Africa, Mundipharma